| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |